Development of Stroke Prognosis Predictive Precision Medicine Based on a Digital Twin
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Stroke.
- Who it may be relevant to
- Registry conditions: Stroke. Basic parameters: from 20 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- South Korea
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A Study for the Development of Prognosis Predictive Precision Medicine Based on a Digital Twin Reflexing the Motor Patterns in Stroke Patients: a Prospective Study
Overview
To collect large-scale, high-quality clinical data, daily activity and movement patterns, and genomic information from stroke patients spanning the subacute to chronic stages. This study aims to establish the foundation for personalized precision medicine in stroke care and to develop a visual and digital transformation of patient medical information in the era of digital healthcare.
Detailed description
This study aims to establish a comprehensive, high-quality dataset that captures the longitudinal characteristics of stroke recovery from the subacute to chronic stages. By integrating clinical data, daily activity and movement patterns, and genomic information, the study reflects the multidimensional nature of stroke in a real-world setting.
The collected data will support data-driven approaches in stroke care by enabling a better understanding of individual variability in recovery trajectories and facilitating the development of predictive models for functional outcomes.
In addition, this study seeks to contribute to personalized precision medicine by enabling individualized interpretation of patient data. It also supports the digital transformation of healthcare by facilitating structured, visual, and data-driven representations of patient medical information for improved clinical and research applications.
Interventions
- Other Stroke
No intervention
Primary outcome measures
- Modified Barthel Index (MBI) [Time frame: minimum <1 months to maximum 6 months]
- Mini Mental Status Examination (MMSE) [Time frame: minimum <1 months to maximum 6 months]
- Functional Ambulatory Category (FAC) [Time frame: minimum <1 months to maximum 6 months]
- Fugl-Meyer Assessment (FMA) [Time frame: minimum <1 months to maximum 6 months]
Eligibility criteria
Inclusion criteria
- Adults aged 20 years or older with a confirmed diagnosis of stroke.
- Within 1 month after stroke onset.
- Patients scoring between 0 and 3 points on the Functional Ambulatory Category (FAC) test.
- Patients or their legally authorized representatives who have fully understood the details of this study, voluntarily decided to participate, and provided written informed consent to comply with the study instructions.
Exclusion criteria
- Patients with impaired ability to provide consent (MMSE score less than 10) who are not accompanied by a caregiver.
- Any other cases deemed inappropriate for participation by the investigator. (This study is non-interventional; therefore, patients who are currently participating in or have participated in another clinical study or research within the past 30 days may still be included.)
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
South Korea · 1 center
- Bundang CHA Medical Center — Gyeonggi-do
Identifiers
NCT: NCT07482579 · 2025-09-038